ATE144558T1 - Oligonukleotiden-sequenzen zur amplifizierung von hiv-2 und siv retrovirusgenomen, ihre verwendung zur in-vitro-diagnostik von durch diese viren verursachten infektionen - Google Patents

Oligonukleotiden-sequenzen zur amplifizierung von hiv-2 und siv retrovirusgenomen, ihre verwendung zur in-vitro-diagnostik von durch diese viren verursachten infektionen

Info

Publication number: ATE144558T1
Authority: AT; Austria
Prior art keywords: viruses; oligonucleotide sequences; infections caused; vitro diagnostics; amplifying hiv
Prior art date: 1989-06-02

Application number

AT90401521T

Other languages

English (en)

Inventor

Pierre Sonigo

Christian Brechot

Valerie Courgnaud

Original Assignee

Pasteur Institut

Inst Nat Sante Rech Med

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-06-02

Filing date

1990-06-05

Publication date

1996-11-15

1990-06-05 Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut

1996-11-15 Application granted granted Critical

1996-11-15 Publication of ATE144558T1 publication Critical patent/ATE144558T1/de

Links

241000700605 Viruses Species 0.000 title abstract 4
208000031886 HIV Infections Diseases 0.000 title abstract 3
241000713340 Human immunodeficiency virus 2 Species 0.000 title abstract 3
108091034117 Oligonucleotide Proteins 0.000 title abstract 2
238000000338 in vitro Methods 0.000 title abstract 2
208000015181 infectious disease Diseases 0.000 title abstract 2
241001430294 unidentified retrovirus Species 0.000 title 1
238000003745 diagnosis Methods 0.000 abstract 1
239000003999 initiator Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
FLNVBBPBGKOJHN-KKAOYSRWSA-N sivmac Chemical compound O=C([C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O FLNVBBPBGKOJHN-KKAOYSRWSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Physics & Mathematics (AREA)
Biotechnology (AREA)
Gastroenterology & Hepatology (AREA)
AIDS & HIV (AREA)
Medicinal Chemistry (AREA)
Analytical Chemistry (AREA)
General Engineering & Computer Science (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT90401521T 1989-06-02 1990-06-05 Oligonukleotiden-sequenzen zur amplifizierung von hiv-2 und siv retrovirusgenomen, ihre verwendung zur in-vitro-diagnostik von durch diese viren verursachten infektionen ATE144558T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8907355A FR2647810B1 (fr)	1989-06-02	1989-06-02	Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus

Publications (1)

Publication Number	Publication Date
ATE144558T1 true ATE144558T1 (de)	1996-11-15

Family

ID=9382332

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90401521T ATE144558T1 (de)	1989-06-02	1990-06-05	Oligonukleotiden-sequenzen zur amplifizierung von hiv-2 und siv retrovirusgenomen, ihre verwendung zur in-vitro-diagnostik von durch diese viren verursachten infektionen

Country Status (11)

Country	Link
US (1)	US6020123A (de)
EP (1)	EP0404625B1 (de)
JP (1)	JPH04505558A (de)
AT (1)	ATE144558T1 (de)
CA (3)	CA2341946C (de)
DE (1)	DE69028951T2 (de)
DK (1)	DK0404625T3 (de)
ES (1)	ES2095241T3 (de)
FR (1)	FR2647810B1 (de)
GR (1)	GR3022248T3 (de)
WO (1)	WO1990015158A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2677039B1 (fr) *	1991-05-31	1994-09-09	Cis Bio Int	Oligonucleotides, utilisables comme reactifs pour la detection in vitro des infections a retrovirus de type hiv et procede de detection de retrovirus de type hiv.
FR2731225B1 (fr) *	1995-03-03	2003-10-31	Pasteur Institut	Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique
AU715731B2 (en)	1994-10-20	2000-02-10	Institut Pasteur	Nucleotide sequences of HIV-1 group (or subtype) O retrovirus antigens
US5962665A (en)	1997-06-16	1999-10-05	Abbott Laboratories	Nucleic acid primers and probes for detecting HIV-1 and HIV-2
US6001558A (en) *	1997-06-25	1999-12-14	Ortho Clinical Diagnostics, Inc.	Amplification and detection of HIV-1 and/or HIV 2
EP1399585B1 (de)	2000-10-23	2008-02-20	Gen-Probe Incorporated	Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
WO2003062377A2 (en) *	2002-01-17	2003-07-31	The Uab Research Foundation	COMPLETE GENOME SEQUENCE OF SIVcpzTAN1
ATE549421T1 (de)	2003-12-19	2012-03-15	Gen Probe Inc	Zusammensetzungen, verfahren und kits zum nachweis der nukleinsäuren von hiv-1 und hiv-2
US8747862B2 (en)	2008-11-14	2014-06-10	Tulane University Health Sciences Center	Pathogenic west african human immunodeficiency virus type 2 (HIV-2) group F isolate
CA2793959C (en)	2010-03-25	2019-06-04	Oregon Health & Science University	Cmv glycoproteins and recombinant vectors
CA2832109C (en)	2011-06-10	2021-07-06	Oregon Health & Science University	Cmv glycoproteins and recombinant vectors
EP2568289A3 (de)	2011-09-12	2013-04-03	International AIDS Vaccine Initiative	Immunselektion von rekombinantem vesikulärem Stomatitisvirus mit Expression von HIV-1-Proteinen durch Breitbandneutralisierungs-Antikörper
ES2631608T3 (es)	2012-06-27	2017-09-01	International Aids Vaccine Initiative	Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en)	2013-09-05	2015-03-05	International Aids Vaccine Initiative	Methods of identifying novel hiv-1 immunogens
US10058604B2 (en)	2013-10-07	2018-08-28	International Aids Vaccine Initiative	Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en)	2015-03-20	2019-01-08	International Aids Vaccine Initiative	Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en)	2015-03-23	2018-04-03	International Aids Vaccine Initiative	Soluble HIV-1 envelope glycoprotein trimers
JP7203017B2 (ja) *	2016-09-07	2023-01-12	セイントヴィンセンツホスピタルシドニーリミテッド	レンチウイルスを検出する方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1341620C (en) *	1984-10-18	2011-08-23	Luc Montagnier	Envelope antigens of hiv-1
AU606043B2 (en) *	1985-03-28	1991-01-31	F. Hoffmann-La Roche Ag	Detection of viruses by amplification and hybridization
US4683195A (en) *	1986-01-30	1987-07-28	Cetus Corporation	Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DE3752319T2 (de) *	1986-01-22	2001-03-15	Pasteur Institut	Prozess zur rekombinanten Herstellung von HIV-2 - Proteinen sowie Zellen, die HIV-2 - Proteine exprimiert
US4839288A (en) *	1986-01-22	1989-06-13	Institut Pasteur	Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
US4806463A (en) *	1986-05-23	1989-02-21	Worcester Foundation For Experimental Biology	Inhibition of HTLV-III by exogenous oligonucleotides
US5030714A (en) *	1986-06-23	1991-07-09	Institut Pasteur	Variant of LAV viruses
WO1988001302A1 (en) *	1986-08-11	1988-02-25	Siska Diagnostics, Inc.	Nucleic acid probe assay methods and compositions
US5079351A (en) *	1986-11-26	1992-01-07	Cetus Corporation	Oligonucleotides and kits for detection of htlvi and htlvii viruses by hybridization
EP0283327B1 (de) *	1987-01-16	1997-06-25	Institut Pasteur	Peptide mit den immunologischen Eigenschaften von HIV-2

1989
- 1989-06-02 FR FR8907355A patent/FR2647810B1/fr not_active Expired - Lifetime
1990
- 1990-04-05 CA CA002341946A patent/CA2341946C/fr not_active Expired - Lifetime
- 1990-06-05 CA CA002592555A patent/CA2592555C/fr not_active Expired - Lifetime
- 1990-06-05 JP JP2509746A patent/JPH04505558A/ja active Pending
- 1990-06-05 DK DK90401521.1T patent/DK0404625T3/da active
- 1990-06-05 DE DE69028951T patent/DE69028951T2/de not_active Expired - Lifetime
- 1990-06-05 ES ES90401521T patent/ES2095241T3/es not_active Expired - Lifetime
- 1990-06-05 EP EP90401521A patent/EP0404625B1/de not_active Expired - Lifetime
- 1990-06-05 AT AT90401521T patent/ATE144558T1/de not_active IP Right Cessation
- 1990-06-05 CA CA002055612A patent/CA2055612C/fr not_active Expired - Lifetime
- 1990-06-05 WO PCT/FR1990/000394 patent/WO1990015158A1/fr not_active Ceased
1994
- 1994-11-18 US US08/343,998 patent/US6020123A/en not_active Expired - Lifetime
1997
- 1997-01-09 GR GR970400012T patent/GR3022248T3/el unknown

Also Published As

Publication number	Publication date
CA2592555C (fr)	2010-01-05
US6020123A (en)	2000-02-01
DK0404625T3 (da)	1997-03-10
FR2647810A1 (fr)	1990-12-07
FR2647810B1 (fr)	1994-07-22
CA2341946C (fr)	2007-10-23
ES2095241T3 (es)	1997-02-16
EP0404625A2 (de)	1990-12-27
WO1990015158A1 (fr)	1990-12-13
EP0404625A3 (de)	1991-01-16
CA2055612A1 (fr)	1990-12-03
GR3022248T3 (en)	1997-04-30
EP0404625B1 (de)	1996-10-23
DE69028951T2 (de)	1997-05-07
CA2592555A1 (fr)	1990-12-13
DE69028951D1 (de)	1996-11-28
CA2341946A1 (fr)	1990-12-13
CA2055612C (fr)	2001-07-31
JPH04505558A (ja)	1992-10-01

Legal Events

Date	Code	Title	Description
1997-06-15	UEP	Publication of translation of european patent specification
2010-09-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
ATE144558T1 (de)	1996-11-15	Oligonukleotiden-sequenzen zur amplifizierung von hiv-2 und siv retrovirusgenomen, ihre verwendung zur in-vitro-diagnostik von durch diese viren verursachten infektionen
WO1990015066A3 (fr)	1991-04-18	Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus
DE69833160D1 (de)	2006-04-06	Amplifizierung und Detektion von HIV-1 und/oder HIV-2
ATE241014T2 (de)	2003-06-15	Hiv-2 varianten
DE3853422D1 (de)	1995-04-27	HIV-3-Retrovirus und seine Verwendung.
ES2013346A6 (es)	1990-05-01	Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles.
DK0702085T3 (da)	2004-04-19	Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
ATE106748T1 (de)	1994-06-15	Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum.
ATE386821T1 (de)	2008-03-15	Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
DK0831899T3 (da)	2008-10-27	Rekombinant koppevirus-calicivirus-præparater og anvendelser
CA2195125A1 (en)	1996-02-01	Difluorostatone antiviral agents
ATE212056T1 (de)	2002-02-15	Methoden zur herstellung von rna viren aus cdna
ATE121779T1 (de)	1995-05-15	Nichtzurückschlagende rns-viren.
ATE337404T1 (de)	2006-09-15	Zur verleihung viraler resistenz an pflanzen geeignetes polyribozym und dieses polyribozym produzierende resistente pflanzen
DK76688A (da)	1988-02-15	Vaccine indeholdende f-proteinet fra aids-virus
Centers for Disease Control and Prevention (CDC	1997	Nonhuman primate spumavirus infections among persons with occupational exposure--United States, 1996
HU896176D0 (en)	1990-02-28	Method for producing of protease, reverse transcriptase and endonuclease of retrovirus
FR2652091B1 (fr)	1994-07-22	Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in-vitro des infections dues a ces virus.
DE60035680D1 (de)	2007-09-06	Komplette gensequenz des esel-leukozyten-impfstoffstammes des equinen infektiösen anemievirus und ihre anwendung
ATE132527T1 (de)	1996-01-15	Nicht-zurückmutierende rna-viren
ATE198602T1 (de)	2001-01-15	Makrocyclische difluorostatonderivate als antivirale mittel